Price increases for generic medications Contents
Witnesses
The following witnesses gave evidence. Transcripts can be viewed on the inquiry publications page of the Committee’s website.
Wednesday 4 July 2018Question number
|
Mark Burdon, Regional Representative, North East and Cumbria, Pharmaceutical Services Negotiating Committee; Warwick Smith, Director General, British Association of Generic Manufacturers; and Professor Karim Meeran, Deputy Director of Medical Education, Imperial College. Sir Chris Wormald, Permanent Secretary, Department of Health and Social Care; Steve Oldfield, Chief Commercial Officer, Department of Health and Social Care; Dr Bruce Warner, Deputy Chief Pharmaceutical Officer, NHS England; and Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency. |
Published: 12 October 2018